Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis

Journal of Medical Virology

Volumn 79, Issue 2, 2007, Pages 192-199

  Mancuso, Roberta ^a   Delbue, Serena ^a,b   Borghi, Elisa ^a   Pagani, Elisabetta ^a,d   Calvo, Maria Gaetana ^a   Caputo, Domenico ^a   Granieri, Enrico ^c   Ferrante, Pasquale ^a,b  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

Cerebrospinal fluid; Multiple Sclerosis; Varicella zoster virus

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONTROLLED STUDY; DNA SEQUENCE; EPSTEIN BARR VIRUS; EVALUATION; FEMALE; GENOME ANALYSIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; JC VIRUS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VARICELLA ZOSTER VIRUS; VIRAL GENETICS; VIRUS DETECTION; VIRUS GENOME; VIRUS REPLICATION;

ADULT; AGED; AGED, 80 AND OVER; CHICKENPOX; DNA, VIRAL; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PREVALENCE;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6; JC POLYOMAVIRUS; SIMPLEXVIRUS;

EID: 33846032263     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20777     Document Type: Article

References (43)

1. Adelman B, Ekman L. 2005. Biogen Idec and Elan announce voluntary suspension of Tysabri®. http://www.Tysabri.com
2. Adelman B, Sandrock A, Panzara MA. 2005. Natalizumab and progressive multifocal leukoencephalopathy. N Engl J Med 353: 432-433.
3. Alvarez-Cermeno JC, Masjuan J, Villar LM. 2005. Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis. N Engl J Med 353:1744-1746.
4. Alvarez-Lafuente R, De las Heras V, Bartolome M, Picazo JJ, Arroyo R. 2004. Relapsing-remitting multiple sclerosis and human herpes-virus 6 active infection. Arch Neurol 61:1523-1527.
5. Berger JR, Koralnik IJ. 2005. Progressive multifocal leukoencephalopathy and natalizumab-unforeseen consequences. N Engl J Med 353:414-416.
6. Boldorini R, Pagani E, Car PG, Omodeo-Zorini E, Borghi E, Tarantini L, Bellotti C, Ferrante P, Monga G. 2003. Molecular characterization of JCV virus strains detected in human brain tumors. Pathology 35:248-253.
7. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M, Schad PA, Stewart PM, Nowinski RC, Brown JP, Burmer GC. 1995. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. PNAS USA 92:7440-7444.
8. Dalgleish AG. 1997. Viruses and multiple sclerosis. Acta Neurol Scand 8169:8-15.
9. Ferrante P, Mancuso R. 1996. Viral cerebrospinal fluid virological analysis in multiple sclerosis. In: Thompson EJ, Trojano M, Livrea P, editors. Cerebrospinal fluid analysis in multiple sclerosis. Milan: Springer-Verlag, pp 1-14.
10. Ferrante P, Omodeo-Zorini E, Zuffolato MR, Mancuso R, Caldarelli-Stefano R, Puricelli S, Mediati M, Losciale L, Caputo D. 1997. Human T-cell lymphotropic virus tax and Epstein-Barr virus DNA in peripheral blood of multiple sclerosis patients during acute attack. Acta Neurol Scand S169:79-85.
11. Ferrante P, Omodeo-Zorini E, Caldarelli-Stefano R, Mediati M, Fainardi E, Granieri E, Caputo D. 1998. Detection of JC virus in cerebrospinal fluid of Multiple sclerosis patients. Mult Scler 4:49-54.
12. Ferrante P, Mancuso R, Pagani E, Guerini FR, Calvo MG, Saresella M, Speciale L, Caputo D. 2000. Molecular evidences for a role of HSV-1 in multiple sclerosis clinical acute attack. J Neurovirol S2:S109-S114.
13. Gabutti G, Penna C, Rossi M, Salmaso S, Rota MC, Bella A, Crovari P. 2001. Serological Study Group. The seroepidemiology of varicella in Italy. Epidemiol Infect 126:433-440.
14. Granieri E, Casetta I, Tola MR, Ferrante P. 2001. Multiple sclerosis: Infectious hypotesis. Neurol Sci 22:179-185.
15. Haahr S, Plesner AM, Vestergaard BF, Hollsberg P. 2004. A role of late Epstein-Barr virus infection in multiple sclerosis. Acta Neurol Scand 109:270-275.
16. Holmoy T, Kyale EO, Vartdal F. 2004. Cerebrospinal fluid CD4 + T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein. J Neurovirol 10:278-283.
17. Hou J, Major EO. 2000. Progressive multifocal leukoencephalopathy: JC virus induced demyelination in the immune compromised host. J Neurovirol 6:98-100.
18. Huang LM, Lee CY, Lee PI, Chen JM, Wang PJ. 1991. Meningitis caused by human herpesvirus-6. Arch Dis Child 66:1443-1444.
19. Hunter SF, Hafler DA. 2000. Ubiquitous pathogens: Links between infection and autoimmunity in MS? Neurology 55:164-165.
20. Ishiguro N, Yamada S, Takahashi T, Takahashi Y, Togashi T, Okuno T, Yamanishi K. 1990. Meningoencephalitis associated with HHV-6 related exanthem subitum. Acta Pediatr Scand 79:987-989.
21. Kleinschmidt-DeMasters BK, Gilden DH. 2001. Varicella-zoster virus infections of nervous system: Clinical and pathologic correlates. Arch Pathol Lab Med 125:770-780.
22. Kleinschmidt-DeMasters BK, Tyler KL. 2005. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 353: 369-374.
23. Kwok S, Higuchi R. 1989. Avoiding false positives with PCR. Nature 339:237-238.
24. Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A. 2003. Multiple sclerosis and Epstein-Barr virus. JAMA 289:1533-1536.
25. Marrie RA, Wolfson C. 2001. Multiple sclerosis and varicella zoster virus infection: A review. Epidemiol Infect 127:315-325.
26. Mazlo M, Holly G, Ressetar HG, Stoner G. 2001. The neuropathology and pathogenesis of progressive multifocal leukoencephalopathy. In: Khalili K, Stoner GL, editors. Human polyomaviruses. Molecular and clinical perspectives. New York: Wiley-Liss. pp 257-335.
27. Monteyne P, Bureau JF, Brahic M. 1998. Viruses and multiple sclerosis. Curr Opin Neurol 11:287-291.
28. Ordonez G, Pineda B, Garcia-Navarrete R, Sotelo J. 2004. Brief presence of varicella-zoster viral DNA in mononuclear cells during relapses of multiple sclerosis. Arch Neurol 61:529-532.
29. Panitch HS. 1994. Influence of infection on exacerbations of multiple sclerosis. Ann Neurol 36:S25-S28.
30. Poser CM. 1993. The pathogenesis of multiple sclerosis. J Neurol Sci 115:S3-S15.
31. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. 1983. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 13:227-231.
32. Prat E, Martin R. 2002. The immunopathogenesis of multiple sclerosis. J Rehabil Res Dev 39:187-199.
33. Ross RT, Cheang M. 1995. Geographic similarities between varicella a and multiple sclerosis: An hypothesis on the environmental factor of multiple sclerosis. J Clin Epidemiol 48:731-737.
34. Saez Torres I, Brieva L, Espejo C, Barrau MA, Montalban X, Martinez-Caceres EM. 2002. Specific proliferation towards myelin antigens in patients with multiple sclerosis during a relapse. Autoimmunity 33:45-50.
35. Sanders VJ, Felisan S, Waddel A, Tourtellotte WW. 1996. Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol 2:249-258.
36. Scarisbrick IA, Rodriguez M. 2003. Hit-Hit and Hit-Run: Viruses in the playing field of multiple sclerosis. Curr Neurol Neurosci Rep 3:165-271.
37. Secchiero P, Carrigan DR, Asano Y, Benedetti L, Crowley RW, Komaroff AL, Gallo RC, Lusso P. 1995. Detection of Human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 171:273-280.
38. Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, Brennan MB, Maloni HW, McFarland HF, Lin HC, Patnaik M, Jacobson S. 1997. Association of human herpesvirus type 6 with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nature Med 3:1394-1397.
39. Steinman L. 2005. Blocking adhesion molecules as therapy for multiple sclerosis: Natalizumab. Nat Rev Drug Discov 4:510-518.
40. Stoner GL. 1991. Implications of progressive multifocal leukoencephalopaty and JC virus for the aetiology of MS. Acta Neurol Scand 83:20-33.
41. Stüve O, Racke M, Hemmer B. 2004. Viral pathogens in multiple sclerosis: An intriguing (hi)story. Arch Neurol 61:1500-1502.
42. Yousry TA, Major EO, Ryschkewitsch C, Fahle G, Fischer S, Hou J, Curfman B, Miszkiel K, Mueller-Lenke N, Sanchez E, Barkhof F, Radue EW, Jager HR, Clifford DB. 2006. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 354:924-933.
43. Yuki N. 2001. Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes. Lancet Infect Dis 1:29-37.